U.S. markets closed

T2 Biosystems, Inc. (TTOO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.8422+0.0219 (+2.67%)
At close: 4:00PM EDT
0.8299 -0.01 (-1.46%)
After hours: 05:31PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close0.8203
Bid0.8295 x 1300
Ask0.8422 x 3000
Day's Range0.8100 - 0.8470
52 Week Range0.8100 - 3.7900
Avg. Volume3,400,403
Market Cap139.676M
Beta (5Y Monthly)0.29
PE Ratio (TTM)N/A
EPS (TTM)-0.2960
Earnings DateNov 02, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for TTOO

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • T2 Biosystems, Inc.
    Large Cap US Pick List - October 2021This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.
    Fair Value
    Economic Moat
    13 days agoMorningstar
View more
  • GlobeNewswire

    T2 Biosystems Appoints Laura Adams to Its Board of Directors

    LEXINGTON, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the appointment of Laura Adams to its Board of Directors, effective immediately. “We are excited to have Laura join the T2 Biosystems Board of Directors,” said John Sperzel, Chairman and CEO at T2 Biosystems. “Her success as a healthcare delivery innovator has deep roots in understanding the critical threats posed by infections and se

  • GlobeNewswire

    T2 Biosystems Reports Granting of Inducement Award

    LEXINGTON, Mass., Oct. 15, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to twenty new employees. The awards were made on October 1, 2021 under T2 Biosystems’ Inducement Award Plan (the "Inducement Plan"), which was adopted on March 1, 2018 and amended and restated on January 8, 2020 and provides for the granting of equity awards to new employees of T2 Biosystems. The induce

  • GlobeNewswire

    T2 Biosystems Showcases Research from Recent Industry Conferences

    Leading rapid diagnostics company shares highlights of comprehensive data presented at AACC, CAP21 and IDWeekLEXINGTON, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced poster session and abstract data showcasing results of its rapid diagnostic technologies at several industry conferences throughout Sepsis Awareness Month. “We are committed to the generation of clinical data to support the ado